Patents by Inventor John F. Templeton

John F. Templeton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cardiac steriod glycosides
    Patent number: 5270457
    Abstract: 14.beta.-hydroxy-3.beta.-(.alpha.-L-rhamnopyranosyl) and-tridigitoxide-oxy-20-nitro-21-nor-5.beta.,14.beta.-pregnanes exhibit unexpectedly high cardiac potency with tolerance to high dosage levels.
    Type: Grant
    Filed: June 12, 1992
    Date of Patent: December 14, 1993
    Assignee: University of Manitoba
    Inventors: Frank S. LaBella, John F. Templeton, Yangzhi Ling
  • Compounds that bind to digitalis receptor
    Patent number: 5144017
    Abstract: Novel steroid compounds which are glycoside derivatives of 14.beta.-hydroxypregnane and 17.alpha.-acetoxy-6.alpha.-methylpregnane are described. The compounds have increased receptor potency when compared to their aglycone and beneficial renal effects.
    Type: Grant
    Filed: January 9, 1990
    Date of Patent: September 1, 1992
    Assignee: University of Manitoba
    Inventors: Frank S. LaBella, John F. Templeton